Screening compound: InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2

Available from 1 mg

Formats:

Glass Vials (4ml Glass Vials VWR #97047-678)
96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Check Price and Availability

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T140-0992

Molecular Formula

C₂₁H₂₂N₂O₄S (C21 H22 N2 O4 S)

Compound Name

4-phenyl-8-(2-phenylacetyl)-1lambda~6~-thia-4,8-diazaspiro[4.5]decane-1,1,3-trione

IUPAC name

4-phenyl-8-(2-phenylacetyl)-1lambda6-thia-48-diazaspiro[4.5]decane-113-trione

SMILES

O=C(Cc1ccccc1)N(CC1)CCC1(N(C(C1)=O)c2ccccc2)S1(=O)=O

InChI

InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2

InChI Key

BSIYIJHFARLVEL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29011562

InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2 in Drug Discovery

Included in Screening Libraries

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Mechanism of action:

PPI modulators
PPI modulators
Receptor's ligands
PPI modulators
PPI modulators

Structure:

Mimetics
Cyclic compounds
Mimetics
Cyclic compounds

Therapeutical areas:

Cancer
Respiratory tract
Eye
Male
Female
Hemic and lymphatic
Congenital
Skin
Endocrine
Immune system
Antiviral
Infections
Immune system

Targets:

Nuclear receptors

References: we are preparing a list of scientific research reports with InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2?
Check Price and Availability of InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.

What is the minimum amount of InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.

Delivery options for InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2
ChemDiv sends parcels with Express services (UPS, WC).

1–2 days for small orders
2–4 weeks for large selections

Delivery formats for InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2

0.5–50 mg of dry powder sample in single glass vials, custom vials
DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H22N2O4S/c24-19(15-17-7-3-1-4-8-17)22-13-11-21(12-14-22)23(18-9-5-2-6-10-18)20(25)16-28(21,26)27/h1-10H,11-16H2 available by request